Illinois Tool Works
ITW NYSE Industrial Machinery & Supplies & Components Financials FY2016βFY2025
Illinois Tool Works' revenue rose 0.9% to $16.0 billion in fiscal 2025. Its operating margin was 26.3%, down from 26.8% a year earlier. Free cash flow was $2.7 billion, down 4.8%. It paid out $3.3 billion in dividends and buybacks, 121% of free cash flow. The diluted share count fell 1.9%.
What Illinois Tool Works does
No business description yet.
- Legal name
- ILLINOIS TOOL WORKS INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000049826-26-000008
0000049826
Revenue and margins
Illinois Tool Works had $16.0B of revenue in fiscal 2025, up 0.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 7.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.7B in fiscal 2025, 16.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Illinois Tool Works returned $3.3B to shareholders in fiscal 2025, 121% of free cash flow. The diluted share count fell 1.9%.
Value Illinois Tool Works yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$8.1B and divides by 292.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 25.0x Β· peers 27.6x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Illinois Tool Works can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.5B | $708M | $1.1B | $948M | $851M |
| Debt incl. finance leases | $8.3B | $8.3B | $9.5B | $7.9B | $9.0B |
| Net debt / EBITDA | 1.8x | 1.9x | 2.0x | 1.5x | 1.8x |
| Debt / equity | 2.3x | 2.7x | 3.2x | 2.4x | 2.8x |
| Interest coverage | 17.2x | 18.7x | 15.2x | 15.1x | 14.4x |
| Current ratio | 1.8x | 1.4x | 1.3x | 1.4x | 1.2x |
| Quick ratio | 1.4x | 1.0x | 1.0x | 1.0x | 0.9x |
| Total assets | $16.1B | $15.4B | $15.5B | $15.1B | $16.1B |
| Total liabilities | $12.5B | $12.3B | $12.5B | $11.8B | $12.9B |
| Shareholders' equity | $3.6B | $3.1B | $3.0B | $3.3B | $3.2B |
| Net debt (β = net cash) | $6.7B | $7.6B | $8.5B | $6.9B | $8.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$1.9M
2 insiders
Sold, 12 months
$67.3M
5 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Ernest Scott SantiDirector | Sold | 41,431 | $287.09 | $11.9M | Form 4 |
| Aug 13, 2026 | Matteo C. PigozzoVP & Chief Accounting Officer | Sold | 277 | $289.22 | $0.1M | Form 4 |
| Jun 2, 2026 | Jennifer F. ScanlonDirector | Bought | 806 | $247.99 | $0.2M | Form 4 |
| Feb 6, 2026 | Mary Katherine LawlerSVP & Chief HR Officer | Sold | 17,279 | $291.90 | $5.0M | Form 4 |
| Feb 5, 2026 | Axel BeckExecutive Vice President | Sold | 4,223 | $290.22 | $1.2M | Form 4 |
| Feb 4, 2026 | Ernest Scott SantiDirector | Sold | 167,345 | $290.93 | $48.7M | Form 4 |
| Dec 10, 2025 | David Byron Smith JrDirector | Bought | 6,709 | $250.13 | $1.7M | Form 4 |
| Nov 5, 2025 | Pamela B StrobelDirector | Sold | 1,521 | $245.25 | $0.4M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 7 / 9 | 6 / 9 |
| Accruals ratio | β3.8% | 1.4% | β0.4% |
| Altman Z'' | 8.36 | 9.12 | 8.54 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Illinois Tool Works ITW | $79.1B | 0.9% | 26.3% | 16.9% | 30.2% | 25.0x | 6 | |
| Stanley Black & Decker SWK | $14.9B | β1.5% | β | 4.6% | 6.2% | 24.2x | 6 | Compare β |
| Otis Worldwide OTIS | $28.8B | 1.2% | 14.8% | 10.0% | 116.6% | 19.3x | 5 | Compare β |
| W. W. Grainger GWW | $63.7B | 4.5% | 13.9% | 7.4% | 32.3% | 34.4x | 6 | Compare β |
| Parker Hannifin PH | $112.8B | 8.3% | 23.6% | 18.2% | 17.6% | 30.9x | 9 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.6B | $14.3B | $14.8B | $14.1B | $12.6B | $14.5B | $15.9B | $16.1B | $15.9B | $16.0B |
| Gross profit | $5.7B | $6.0B | $6.2B | $5.9B | $5.2B | $6.0B | $7.8B | $8.2B | $8.3B | $8.5B |
| Research and development | $223M | $225M | $233M | $221M | $214M | $239M | $269M | $284M | $292M | $302M |
| Operating income | $3.1B | $3.5B | $3.6B | $3.4B | $2.9B | $3.5B | $3.8B | $4.0B | $4.3B | $4.2B |
| Interest expense | $237M | $260M | $257M | $221M | $206M | $202M | $203M | $266M | $283M | $292M |
| Pretax income | $2.9B | $3.3B | $3.4B | $3.3B | $2.7B | $3.3B | $3.8B | $3.8B | $4.4B | $4.0B |
| Income tax | $873M | $1.6B | $831M | $767M | $595M | $632M | $808M | $866M | $934M | $900M |
| Net income | $2.0B | $1.7B | $2.6B | $2.5B | $2.1B | $2.7B | $3.0B | $3.0B | $3.5B | $3.1B |
| Diluted EPS | $5.70 | $4.86 | $7.60 | $7.74 | $6.63 | $8.51 | $9.77 | $9.74 | $11.71 | $10.49 |
| Diluted shares | 0.36B | 0.35B | 0.34B | 0.33B | 0.32B | 0.32B | 0.31B | 0.30B | 0.30B | 0.29B |
| Cash flow | ||||||||||
| Cash from operations | $2.3B | $2.4B | $2.8B | $3.0B | $2.8B | $2.6B | $2.3B | $3.5B | $3.3B | $3.1B |
| Capital expenditure | $273M | $297M | $364M | $326M | $236M | $296M | $412M | $455M | $437M | $419M |
| Free cash flow | $2.0B | $2.1B | $2.4B | $2.7B | $2.6B | $2.3B | $1.9B | $3.1B | $2.8B | $2.7B |
| Depreciation and amortization | $246M | $256M | $272M | $267M | $273M | $277M | $276M | $282M | $301M | $317M |
| Stock-based compensation | $39.0M | $36.0M | $40.0M | $41.0M | $42.0M | $53.0M | $63.0M | $69.0M | $61.0M | $69.0M |
| Acquisitions | $453M | $3.0M | $0.0M | $4.0M | $0.0M | $731M | $2.0M | $0.0M | $115M | $119M |
| Share buybacks | $2.0B | $1.0B | $2.0B | $1.5B | $706M | $1.0B | $1.8B | $1.5B | $1.5B | $1.5B |
| Dividends paid | $821M | $941M | $1.1B | $1.3B | $1.4B | $1.5B | $1.5B | $1.6B | $1.7B | $1.8B |
| Dividends and buybacks | $2.8B | $1.9B | $3.1B | $2.8B | $2.1B | $2.5B | $3.3B | $3.1B | $3.2B | $3.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $2.5B | $3.1B | $1.5B | $2.0B | $2.6B | $1.5B | $708M | $1.1B | $948M | $851M |
| Total debt | $7.8B | $8.3B | $7.4B | $7.8B | $8.5B | $8.3B | $8.3B | $9.5B | $7.9B | $9.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $6.1B | $7.3B | $5.8B | $6.3B | $6.5B | $6.4B | $6.3B | $6.2B | $5.9B | $6.2B |
| Current liabilities | $2.8B | $3.1B | $3.5B | $2.2B | $2.6B | $3.5B | $4.5B | $4.7B | $4.3B | $5.1B |
| Inventory | $1.1B | $1.2B | $1.3B | $1.2B | $1.2B | $1.7B | $2.1B | $1.7B | $1.6B | $1.7B |
| Property and equipment, net | $1.7B | $1.8B | $1.8B | $1.7B | $1.8B | $1.8B | $1.8B | $2.0B | $2.0B | $2.2B |
| Total assets | $15.2B | $16.8B | $14.9B | $15.1B | $15.6B | $16.1B | $15.4B | $15.5B | $15.1B | $16.1B |
| Total liabilities | $10.9B | $12.2B | $11.6B | $12.0B | $12.4B | $12.5B | $12.3B | $12.5B | $11.8B | $12.9B |
| Shareholders' equity | $4.3B | $4.6B | $3.3B | $3.0B | $3.2B | $3.6B | $3.1B | $3.0B | $3.3B | $3.2B |
| Margins | ||||||||||
| Gross margin | 41.9% | 42.0% | 41.7% | 42.0% | 41.4% | 41.3% | 48.9% | 50.7% | 52.2% | 52.9% |
| Operating margin | 22.5% | 24.4% | 24.3% | 24.1% | 22.9% | 24.1% | 23.8% | 25.1% | 26.8% | 26.3% |
| EBITDA margin | 24.3% | 26.1% | 26.1% | 26.0% | 25.1% | 26.0% | 25.5% | 26.8% | 28.7% | 28.3% |
| Net margin | 15.0% | 11.8% | 17.4% | 17.9% | 16.8% | 18.6% | 19.0% | 18.4% | 21.9% | 19.1% |
| FCF margin | 14.9% | 14.7% | 16.6% | 18.9% | 20.5% | 15.6% | 12.2% | 19.2% | 17.9% | 16.9% |
| Returns | ||||||||||
| Return on capital | 22.3% | 18.5% | 28.6% | 29.1% | 25.1% | 29.0% | 28.5% | 28.2% | 31.0% | 30.2% |
| Return on capital employed | 23.7% | 26.6% | 28.6% | 28.1% | 22.2% | 27.1% | 32.2% | 37.1% | 39.5% | 38.7% |
| Return on equity | 42.9% | 38.1% | 65.3% | 80.2% | 67.9% | 79.1% | 90.4% | 96.9% | 110.2% | 93.7% |
| Return on assets | 13.2% | 10.6% | 16.2% | 16.8% | 13.8% | 17.0% | 19.3% | 19.1% | 22.8% | 19.6% |
| Growth | ||||||||||
| Revenue growth | 1.5% | 5.3% | 3.2% | β4.5% | β10.9% | 15.0% | 10.2% | 1.1% | β1.3% | 0.9% |
| Net income growth | 7.2% | β17.1% | 51.9% | β1.6% | β16.3% | 27.7% | 12.6% | β2.5% | 18.0% | β12.1% |
| EPS growth | 11.1% | β14.7% | 56.4% | 1.8% | β14.3% | 28.4% | 14.8% | β0.3% | 20.2% | β10.4% |
| FCF growth | 0.7% | 3.8% | 16.3% | 9.1% | β3.7% | β12.1% | β14.4% | 59.3% | β7.8% | β4.8% |
| Share count change | β3.5% | β2.9% | β2.8% | β3.4% | β2.2% | β0.6% | β1.8% | β2.3% | β1.9% | β1.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.6x | 1.4x | 1.5x | 1.6x | 1.9x | 1.8x | 1.9x | 2.0x | 1.5x | 1.8x |
| Debt / equity | 1.8x | 1.8x | 2.3x | 2.6x | 2.7x | 2.3x | 2.7x | 3.2x | 2.4x | 2.8x |
| Interest coverage | 12.9x | 13.4x | 14.0x | 15.4x | 14.0x | 17.2x | 18.7x | 15.2x | 15.1x | 14.4x |
| Current ratio | 2.2x | 2.4x | 1.6x | 2.9x | 2.5x | 1.8x | 1.4x | 1.3x | 1.4x | 1.2x |
| Quick ratio | 1.8x | 2.0x | 1.3x | 2.4x | 2.1x | 1.4x | 1.0x | 1.0x | 1.0x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.0% | 2.1% | 2.5% | 2.3% | 1.9% | 2.1% | 2.6% | 2.8% | 2.8% | 2.6% |
| Stock comp / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% |
| Payouts / FCF | 139.0% | 92.2% | 127.7% | 105.7% | 81.1% | 108.9% | 170.0% | 101.0% | 112.3% | 121.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 7.0 | 6.0 | 8.0 | 4.0 | 6.0 | 6.0 | 7.0 | 7.0 | 6.0 |
| Altman Z'' | 7.4 | 7.4 | 7.6 | 8.4 | 8.0 | 7.9 | 8.1 | 8.4 | 9.1 | 8.5 |
| Accruals ratio | β1.7% | β4.5% | β1.6% | β3.2% | β4.6% | 0.9% | 4.4% | β3.8% | 1.4% | β0.4% |
Source: SEC EDGAR XBRL filings (CIK 0000049826). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.